A citation-based method for searching scientific literature

F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. N Engl J Med 2010
Times Cited: 10046







List of co-cited articles
863 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Yusuke Mochizuki, Hiroshi Tazawa, Koji Demiya, Miho Kure, Hiroya Kondo, Tadashi Komatsubara, Kazuhisa Sugiu, Joe Hasei, Aki Yoshida, Toshiyuki Kunisada,[...]. Cancer Immunol Immunother 2021
7
14

Osteosarcoma Pathogenesis Leads the Way to New Target Treatments.
Isabel Fernandes, Cecília Melo-Alvim, Raquel Lopes-Brás, Miguel Esperança-Martins, Luís Costa. Int J Mol Sci 2021
11
9

Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.
Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek,[...]. Oncotarget 2017
49
2

Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma.
Wataru Takenaka, Yutaka Takahashi, Keisuke Tamari, Kazumasa Minami, Shohei Katsuki, Yuji Seo, Fumiaki Isohashi, Masahiko Koizumi, Kazuhiko Ogawa. Cancers (Basel) 2020
8
12

Regulation of PD-L1 expression in the tumor microenvironment.
Ming Yi, Mengke Niu, Linping Xu, Suxia Luo, Kongming Wu. J Hematol Oncol 2021
94
1

Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapy.
Lei Li, Jia-Ru Wei, Jun Dong, Qing-Guang Lin, Hong Tang, Yong-Xu Jia, Wanlin Tan, Qing-Yun Chen, Ting-Ting Zeng, Shan Xing,[...]. Sci Adv 2021
14
7

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.
Francesca Garofano, Maria A Gonzalez-Carmona, Dirk Skowasch, Roland Schmidt-Wolf, Alina Abramian, Stefan Hauser, Christian P Strassburg, Ingo G H Schmidt-Wolf. Int J Mol Sci 2019
21
4

Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.
Taylor T Chrisikos, Yifan Zhou, Natalie Slone, Rachel Babcock, Stephanie S Watowich, Haiyan S Li. Mol Immunol 2019
24
4

Osteosarcoma and Metastasis.
Gaohong Sheng, Yuan Gao, Yong Yang, Hua Wu. Front Oncol 2021
14
7

Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
Sean J Judge, Morgan A Darrow, Steve W Thorpe, Alicia A Gingrich, Edmond F O'Donnell, Alyssa R Bellini, Ian R Sturgill, Logan V Vick, Cordelia Dunai, Kevin M Stoffel,[...]. J Immunother Cancer 2020
26
3

Immune classification of osteosarcoma.
Trang Le, Sumeyye Su, Leili Shahriyari. Math Biosci Eng 2021
11
9

Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R Ramjiawan, Arjan W Griffioen, Dan G Duda. Angiogenesis 2017
326
1

Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies.
Guillermo Garcia-Manero, Hartmut Döhner, Andrew H Wei, Ignazia La Torre, Barry Skikne, C L Beach, Valeria Santini. Clin Lymphoma Myeloma Leuk 2022
3
33

Necroptosis in Immuno-Oncology and Cancer Immunotherapy.
Jenny Sprooten, Pieter De Wijngaert, Isaure Vanmeerbeerk, Shaun Martin, Peter Vangheluwe, Susan Schlenner, Dmitri V Krysko, Jan B Parys, Geert Bultynck, Peter Vandenabeele,[...]. Cells 2020
42
2

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
Kalijn F Bol, Gerty Schreibelt, Winald R Gerritsen, I Jolanda M de Vries, Carl G Figdor. Clin Cancer Res 2016
206
1

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1.
Emanuela Palmerini, Claudio Agostinelli, Piero Picci, Stefano Pileri, Teresa Marafioti, Pier-Luigi Lollini, Katia Scotlandi, Alessandra Longhi, Maria Serena Benassi, Stefano Ferrari. Oncotarget 2017
34
2

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.
Sergei R Guma, Dean A Lee, Ling Yu, Nancy Gordon, Dennis Hughes, John Stewart, Wei Lien Wang, Eugenie S Kleinerman. Pediatr Blood Cancer 2014
33
3

Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma.
Wenhui Ge, Jing Li, Wenhao Fan, Delong Xu, Shangfei Sun. Tumour Biol 2017
20
5

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma.
Chuangzhong Deng, Yanyang Xu, Jianchang Fu, Xiaojun Zhu, Hongmin Chen, Huaiyuan Xu, Gaoyuan Wang, Yijiang Song, Guohui Song, Jinchang Lu,[...]. Cancer Sci 2020
33
3


Immunotherapy and pancreatic cancer: unique challenges and potential opportunities.
Kate Young, Daniel J Hughes, David Cunningham, Naureen Starling. Ther Adv Med Oncol 2018
35
2

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
Eric Tartour, H Pere, B Maillere, M Terme, N Merillon, J Taieb, F Sandoval, F Quintin-Colonna, K Lacerda, A Karadimou,[...]. Cancer Metastasis Rev 2011
221
1


Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent.
Anke E M van Erp, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen, Laurens van Houdt, Mark A J Gorris, Laura S van Dam, Thomas Mentzel, Marije E Weidema, C Dilara Savci-Heijink, Ingrid M E Desar,[...]. Oncotarget 2017
54
1

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
Marna G Bouwhuis, Andreas Gast, Adina Figl, Alexander M M Eggermont, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar. Cancer Immunol Immunother 2010
45
2

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.
Francesca Cersosimo, Silvia Lonardi, Giulia Bernardini, Brian Telfer, Giulio Eugenio Mandelli, Annalisa Santucci, William Vermi, Emanuele Giurisato. Int J Mol Sci 2020
48
2

The PD-1/PD-Ls pathway and autoimmune diseases.
Suya Dai, Ru Jia, Xiao Zhang, Qiwen Fang, Lijuan Huang. Cell Immunol 2014
221
1

Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation.
Jay S Wunder, Minji J Lee, Junghyun Nam, Beatrice Y Lau, Brendan C Dickson, Dushanthi Pinnaduwage, Shelley B Bull, Peter C Ferguson, Andrew Seto, Nalan Gokgoz,[...]. Oncoimmunology 2020
10
10

Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.
Hiroshi Tazawa, Shinji Kuroda, Joe Hasei, Shunsuke Kagawa, Toshiyoshi Fujiwara. Int J Mol Sci 2017
32
3

Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.
Alka Bhatia, Yashwant Kumar. Expert Rev Clin Immunol 2014
78
1

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.
Roman Groisberg, David S Hong, Amini Behrang, Kenneth Hess, Filip Janku, Sarina Piha-Paul, Aung Naing, Siqing Fu, Robert Benjamin, Shreyaskumar Patel,[...]. J Immunother Cancer 2017
79
1

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.
Pratistha Koirala, Michael E Roth, Jonathan Gill, Sajida Piperdi, Jordan M Chinai, David S Geller, Bang H Hoang, Amy Park, Michael A Fremed, Xingxing Zang,[...]. Sci Rep 2016
159
1



Future Directions in the Treatment of Osteosarcoma.
Alannah Smrke, Peter M Anderson, Ashish Gulia, Spyridon Gennatas, Paul H Huang, Robin L Jones. Cells 2021
41
2

Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
Pooja Dhupkar, Nancy Gordon, John Stewart, Eugenie S Kleinerman. Cancer Med 2018
82
1

Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.
Yoshiyuki Suehara, Deepu Alex, Anita Bowman, Sumit Middha, Ahmet Zehir, Debyani Chakravarty, Lu Wang, George Jour, Khedoudja Nafa, Takuo Hayashi,[...]. Clin Cancer Res 2019
42
2

New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma.
Xingyu Chang, Zhanjun Ma, Guomao Zhu, Yubao Lu, Jingjing Yang. J Bone Oncol 2021
12
8

IFNγ and TNFα synergistically promote galectin 9 secretion by human osteosarcoma cells MG-63 to prevent T cell killing.
Yuchang Liu, Junzhong Luo, Yazhou Li, Jinchao Cao, Xuan Wang. Int J Clin Exp Pathol 2020
1
100

Update on Osteosarcoma.
Rebekah Belayneh, Mitchell S Fourman, Sumail Bhogal, Kurt R Weiss. Curr Oncol Rep 2021
24
4

Osteosarcoma.
Bree R Eaton, Rudolf Schwarz, Ralph Vatner, Brian Yeh, Line Claude, Daniel J Indelicato, Nadia Laack. Pediatr Blood Cancer 2021
35
2

High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells.
Tiara Bunga Mayang Permata, Hiro Sato, Wenchao Gu, Sangeeta Kakoti, Yuki Uchihara, Yukihiko Yoshimatsu, Itaru Sato, Reona Kato, Motohiro Yamauchi, Keiji Suzuki,[...]. J Radiat Res 2021
4
25

Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma.
Yutaka Takahashi, Tomohiro Yasui, Kazumasa Minami, Keisuke Tamari, Kazuhiko Hayashi, Keisuke Otani, Yuji Seo, Fumiaki Isohashi, Masahiko Koizumi, Kazuhiko Ogawa. Oncotarget 2019
32
3


Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.
N Erfani, M Razmkhah, A R Talei, A M Pezeshki, M Doroudchi, A Monabati, A Ghaderi. Cancer Genet Cytogenet 2006
71
1

Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer.
Xinge Shi, Xiqing Li, Hongqiang Wang, Zhenghong Yu, Yu Zhu, Yanzheng Gao. J Bone Oncol 2018
11
9

Metabolic Implications of Immune Checkpoint Proteins in Cancer.
Elizabeth R Stirling, Steven M Bronson, Jessica D Mackert, Katherine L Cook, Pierre L Triozzi, David R Soto-Pantoja. Cells 2022
3
33

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.
Neel I Nissen, Morten Karsdal, Nicholas Willumsen. J Exp Clin Cancer Res 2019
182
1

Oncolytic viruses for cancer immunotherapy.
Otto Hemminki, João Manuel Dos Santos, Akseli Hemminki. J Hematol Oncol 2020
60
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.